1/6/2021 · Lactobacillus reuteri is a species of probiotic bacteria. It may provide some benefits for cholesterol levels, reducing H. pylori levels (the pathogenic bacterium which contributes to ulcers), female urinary tract and vaginal health, and infant gastrointestinal health.
Lactobacillus reuteri ATCC 55730 is a probiotic (health-promoting) bacterium widely used as a dietary supplement. This study was designed to examine local colonization of the human gastrointestinal mucosa after dietary supplementation with L . reuteri ATCC 55730 and to determine subsequent immune responses at the colonized sites.
The aim of the present study was to evaluate the effects of L . reuteri in adult patients with functional constipation. Methods: A double-blind, placebo RCT was conducted in 40 adults (18M/22F, 35+/-15 years) affected by functional constipation according to the Rome III criteria. Patients were randomly assigned to receive a supplementation of L …
10/16/2019 · L. reuteri is being researched for its effects against pneumoviruses , circoviruses, rotaviruses, coxsackieviruses, and papillomaviruses . It has been suggested that L. reuteri ameliorates viral infection by regulating the microbiota, The molecular mechanisms of pro-apoptotic effects of human-derived Lactobacillus reuteri ATCC PTA 6475 were investigated in this study. L . reuteri secretes factors that potentiate apoptosis in myeloid leukemia-derived cells induced by tumour necrosis factor (TNF), as indicated by intracellular esterase activity, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end …
Emerging evidence indicates the gut microbiome plays a role in bone health, and several animal studies have suggested that Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475) can increase bone mineral density and reduce bone loss. The study under review is the first human intervention to evaluate how L. reuteri 6475 affects bone health.
6/21/2018 · The objective of this trial was to investigate if L. reuteri 6475 affects bone loss in older women with low BMD. Methods. In this double?blind, placebo?controlled study, women from the population who were 75 to 80 years old and had low BMD were randomized to orally receive 10 10 colony?forming units of L. reuteri 6475 daily or placebo. The predefined primary end?point was.
Examine .com is an independent educational organization that researches nutrition information – and nothing more. 100% backed by science, we take an independent and unbiased approach to figure out what works (and what’s a waste of time and money). Arm yourself with the knowledge needed to make the right decisions to improve your health.
Lactobacillus Rhamnosus, Lactobacill…, Lactobacillus acidophilus, Lactobacillus Fermentum, Lactobacillus Casei
